Polar Capital Holdings’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,500,000
| Closed | -$23.6M | – | 300 |
|
|
2024
Q1 | $23.6M | Sell |
1,500,000
-350,000
| -19% | -$5.51M | 0.12% | 136 |
|
|
2023
Q4 | $29.8M | Buy |
1,850,000
+100,000
| +6% | +$1.61M | 0.18% | 109 |
|
|
2023
Q3 | $22.3M | Hold |
1,750,000
| – | – | 0.17% | 134 |
|
|
2023
Q2 | $24.6M | Hold |
1,750,000
| – | – | 0.12% | 128 |
|
|
2023
Q1 | $27M | Buy |
1,750,000
+500,000
| +40% | +$7.73M | 0.18% | 120 |
|
|
2022
Q4 | $20.5M | Hold |
1,250,000
| – | – | 0.16% | 145 |
|
|
2022
Q3 | $23.1K | Sell |
1,250,000
-250,000
| -17% | -$4.63K | 0.15% | 130 |
|
|
2022
Q2 | $19.7K | Buy |
+1,500,000
| New | +$19.7K | 0.12% | 147 |
|
|
2022
Q1 | – | Sell |
-163,100
| Closed | -$1.59K | – | 487 |
|
|
2021
Q4 | $1.59K | Sell |
163,100
-400,000
| -71% | -$3.91K | 0.01% | 305 |
|
|
2021
Q3 | $19.1K | Buy |
563,100
+163,100
| +41% | +$5.54K | 0.08% | 173 |
|
|
2021
Q2 | $14.6K | Hold |
400,000
| – | – | 0.06% | 198 |
|
|
2021
Q1 | $17.9M | Buy |
400,000
+50,000
| +14% | +$2.24M | 0.11% | 166 |
|
|
2020
Q4 | $20M | Buy |
+350,000
| New | +$20M | 0.12% | 159 |
|